MedTrace Logo

PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark

NCT05570279 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 314

Last updated 2024-08-14

No results posted yet for this study

Summary

The study is a prospective registration of treatment related-, toxicity-, Quality of life- and outcome data from patients treated in Denmark with radiotherapy for squamous cell carcinoma of the anus (SCCA), as a cooperation within the Danish Anal Cancer Group (DACG).

Substudy one: A prospective biobank is collected with the purpose to identify predictive and prognostic markers for outcome.

Substudy two: MRI scans are performed to investigate the rate of pelvic insufficience fractures at one year post chemoradiotherapy.

Conditions

Sponsors & Collaborators

  • Herlev Hospital

    collaborator OTHER

  • Vejle Hospital

    collaborator OTHER

  • Aarhus University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2025-04-01
Completion
2026-04-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05570279 on ClinicalTrials.gov